Abstract:Background Metastasis is a complex multistep process: cancer cells have to detach from the bulk of the primary tumor, intravasate into the blood, survive anoikis and high shear forces in the blood, extravasate to a distal site, and finally proliferate to form metastatic nodules. It is unclear what molecular mechanisms enable some cancer cells to go through every step in the metastatic cascade. In particular, it is not known if the rare tumor cells that enter the circulation and grow at a distal site are metabolically different from the bulk of primary tumor cells, and if any such metabolic differences are important for metastasis. Results Melanomas taken directly from patients were serially xeno-transplanted subcutaneously in severely immunocompromised mice. Distant metastasis in the mouse correlated strongly with distant metastasis in patients. Metabolomic profiling showed several metabolic differences between primary tumors and corresponding metastatic nodules. We are testing if these metabolic differences can control cellular signaling pathways, and if manipulation of metabolism can affect metastasis in vivo. Additionally, we are exploring differences in the mitochondrial biology of primary tumors and metastatic nodules. Finally, we are developing a method to detect the metabolic profile of rare circulating tumor cells using the same melanoma xenograft model in order to track the metabolic changes in melanoma cells at every step of the metastatic cascade. Conclusions Identification of metabolic changes that occur during the metastatic cascade raises the possibility that metabolism is functionally important not only for primary tumor growth but also for tumor survival in the blood, colonization of distal organs, and formation of overt metastatic nodules. More detailed understanding of these metabolic mechanisms will allow us to identify new therapeutic targets to block metastasis.

Melanoma Metabolism: Molecular Mechanisms and Therapeutic Implications in Cutaneous Oncology

Metabolic Rewiring Directs Melanoma Immunology

Mitochondrial Metabolism in Melanoma

Metabolic Plasticity of Melanoma Cells and Their Crosstalk With Tumor Microenvironment

Interaction of Molecular Alterations with Immune Response in Melanoma

The metabolism of melanin synthesis—From melanocytes to melanoma

Therapeutic implications of the metabolic changes associated with BRAF inhibition in melanoma

Unraveling lipid metabolism reprogramming for overcoming drug resistance in melanoma

Metabolic Plasticity in Melanoma Progression and Response to Oncogene Targeted Therapies

Exploring the Complex and Multifaceted Interplay between Melanoma Cells and the Tumor Microenvironment

Advances in Targeted Therapies and Combination Approaches for Melanoma: A Comprehensive Review

Metabolic Mechanisms Regulating Distinct Steps of the Melanoma Metastatic Cascade

Metabolic Interplay in the Tumor Microenvironment: Implications for Immune Function and Anticancer Response

Metabolic Alterations in Cancer Cells and Therapeutic Implications.

Metabolic reprogramming in tumor immune microenvironment: Impact on immune cell function and therapeutic implications

Metabolism heterogeneity in melanoma fuels deactivation of immunotherapy: Predict before protect

Advances in Understanding Drug Resistance Mechanisms and Innovative Clinical Treatments for Melanoma

The Emerging Roles of Metabolism in the Crosstalk Between Breast Cancer Cells and Tumor-Associated Macrophages

Metabolic modulation of cancer: a new frontier with great translational potential

Altered metabolism in cancer: insights into energy pathways and therapeutic targets

Cutaneous melanoma: From pathogenesis to therapy (Review)